Search Constraints
Search Results
Select an image to start the slideshow
Strategies for engineering γδ T cells to treat pediatric cancers
1 of 17
Siglec-15 is required for evasion of immune response in acute lymphoblastic leukemia
2 of 17
Immunologic Mechanisms of Colorectal Liver Metastases: Potential for Novel Therapies
3 of 17
MEK inhibition mediates immunomodulatory factors and cell populations in advanced biliary tract cancer
4 of 17
Understanding and Optimizing Gamma-Delta T cells as a Platform for Cellular Immunotherapies
5 of 17
B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12
6 of 17
Modulating Mitofusins to Enhance Therapeutic T Cell Expansion and Persistence
7 of 17
An intratumoral immune niche sustains the anti-tumor immune response and supports the response to immunotherapy
8 of 17
Galectin-9 Expression and its Role in Biliary Tract Cancers
9 of 17
Elucidating the Role of Soluble Galectin-9 in B-cell Acute Lymphoblastic Leukemia Pathogenesis
10 of 17
Evaluation of tumor membrane vesicle (TMV) vaccine immunotherapy in a HER2+ TUBO murine breast cancer model
11 of 17
Inhibiting VIP Receptor Signaling Promotes T Cell Mediated Immune Response in Murine Melanoma Models
12 of 17
Vasoactive Intestinal Peptide Antagonist Enhances T cell Proliferation and Synergizes with PD-1 Antibodies to Promote Anti-Melanoma T cell Immune Responses
13 of 17
Protein transfer-mediated modification of virus-like particles and plasma membrane vesicles: A means to adjuvant and deliver tumor antigens
14 of 17
Common gamma-chain (ϒc) cytokine-based fusion proteins forapplications in immunotherapy
15 of 17
Heat Shock Factor 1 Regulation of Multiple Myeloma Pathogenesis
16 of 17
Induction of Anti-Tumor Immunity in an Immune Checkpoint
Inhibitor Resistant Murine Lung Cancer
17 of 17